Key result
Polycystic ovary syndrome linked to differences in BMI, WHR, and insulin levels versus healthy women.
Why the study?
Polycystic ovary syndrome contributes to metabolic problems related to insulin resistance and hyperandrogenism and is closely related to body mass index, but the impact of age and BMI on hormonal disruption in PCOS is unclear.
Case-Control (n=350)
Answers are grounded in this paper and cite their sources.
PCOS women present with hyperandrogenism, insulin resistance, and low HDL-C levels, but changes in sex hormone levels had no significant impact on age or BMI in this South Indian cohort.
Introduction and Aim: Polycystic ovary syndrome is a diverse condition that contributes to metabolic problems like insulin resistance and hyperandrogenism which women experience during their reproductive years, and it is closely related to the body mass index. The purpose of this study was to evaluate the clinical, biochemical, and hormonal profiles of PCOS patients and healthy women concerning age and BMI and to correlate insulin with other parameters. Materials and Methods: The present case-control study was conducted from June 2019-April 2021. 180 PCOS women and 170 age-matched healthy women were enrolled from Mangalore, Karnataka. Anthropometric measurements, biochemical, hormonal profile, and the presence of IR were estimated in all patients and were further subdivided based on age and BMI. Results: The mean age of patients with PCOS and controls was 25.9± 5.6 years vs 24.7 ± 6.8 years. BMI and WHR had statistical significance (p<0.01) between the groups. TG & HDL showed statistical significance (p<0.05) in both age groups who were underweight and had normal BMI. A significant difference (p<0.05) was also observed in plasma insulin and HOMA-IR in all groups except in women who were obese. Conclusion: PCOS women were presented with hyperandrogenism and had metabolic risk factors like insulin resistance and low HDL-C levels at budding age and increased BMI. When comparing women with and without PCOS from the south Indian state of Karnataka, our findings revealed that changes in sex hormone levels had no significant impact on age or BMI.
No takes yet. Share an insight, caveat, or question.
Hegde et al. (2022) conducted a case-control in Polycystic ovary syndrome (n=350). Polycystic ovary syndrome vs. Healthy women was evaluated on BMI and WHR (p=<0.01). Polycystic ovary syndrome was associated with significant differences in BMI and WHR, as well as plasma insulin and HOMA-IR, compared to healthy age-matched women.
Synapse has enriched 10 related papers. Consider them for comparative context: